VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Activity

116 hedge funds and large institutions have $168M invested in VistaGen Therapeutics in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 39 reducing their positions, and 9 closing their positions.

Holders
116
Holders Change
+10
Holders Change %
+9.43%
% of All Funds
1.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
30
Reduced
39
Closed
9
Calls
$41K
Puts
$487K
Net Calls
-$446K
Net Calls Change
+$520K

Top Buyers

1
CC
1
Commodore Capital
New York
$12.5M
2
Norges Bank
2
Norges Bank
Norway
$1.64M
3
Millennium Management
3
Millennium Management
New York
$1.54M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.46M
5
SFM
5
Sphera Funds Management
Israel
$6.14M

Top Sellers

1
State Street
1
State Street
Massachusetts
$4.48M
2
LGM
2
Logos Global Management
California
$1.24M
3
Rafferty Asset Management
3
Rafferty Asset Management
New York
$0
4
GTC
4
Ghost Tree Capital
New York
$1.63M
5
SCM
5
Silverarc Capital Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
126
Simplex Trading
Illinois
– – – –
HT
127
HAP Trading
New York
– – – –
SM
128
Sabby Management
Florida
– – – –
Fidelity Investments
129
Fidelity Investments
Massachusetts
$0 675 +242 +56%
2 3 4 5
6